Company intelligence / Profile preview

Lux Capital

New York City, New York, United Statesluxcapital.com ↗

Ownership: Private
Employees: ~30
Development stage: Other

Overview

Lux Capital invests in early-stage and growth-stage science-driven startups across biotech and healthcare. Its portfolio includes leading-edge companies advancing new drug discovery platforms and novel therapeutic approaches but it does not conduct clinical trials or report clinical results directly.

Industry: Investors

Partnerships

As a venture funder/investor—no direct pharma partnerships but many of its investee firms partner with major pharmaceutical or technology players.

Beyond the preview

Go deeper on Lux Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lux Capital.

Explore the full profile